US Patent Litigations are now available. Check here

PatentPatent Analysis

EP2357250

PFIZER IRELAND PHARMACEUTICALS
Application Number
EP11156236A
Filing Date
Aug 26, 2005
Status
Revoked
Mar 24, 2023
Grant Date
Oct 6, 2021
External Links
Slate, Register, Google Patents
Similar Patents facing opposition

Biblio Summary

The patent EP2357250B1 was granted on Oct 6, 2021 by Pfizer Ireland Pharmaceuticals The patent is currently Revoked.

Patent citations in opposition refer to prior patents or publications that may challenge the validity of a contested patent. These references help assess whether the invention is truly novel or overlaps with existing intellectual property.

Citation PhasePatent NumberPatent LinkCited Text
OppositionUS5122469
N/A
OppositionUS6180401
N/A
OppositionUS6048728
N/A
OppositionWO02101019
N/A
OppositionWO2006026447
N/A
OppositionUS2003087372
N/A
OppositionUS6656466
N/A
OppositionUS6924124
N/A
OppositionEP1992697
N/A

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.